April 2, 2018 / 8:13 PM / 6 months ago

BRIEF-Cancer Genetics Reports Q4 Loss Per Share Of $0.35

April 2 (Reuters) - Cancer Genetics Inc:

* CANCER GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES STRATEGIC BUSINESS UPDATES

* Q4 REVENUE $7.5 MILLION VERSUS I/B/E/S VIEW $9.2 MILLION

* Q4 EARNINGS PER SHARE VIEW $-0.11 -- THOMSON REUTERS I/B/E/S

* HAS UNDERTAKEN A "COMPREHENSIVE AND EXTENSIVE" REVIEW OF ITS STRATEGY AND ORGANIZATION

* ENGAGED RAYMOND JAMES & ASSOCIATES INC AS A FINANCIAL ADVISOR TO ASSIST WITH EVALUATING OPTIONS FOR COMPANY'S STRATEGIC DIRECTION

* OPTIONS FOR CO'S STRATEGIC DIRECTION MAY INCLUDE RAISING ADDITIONAL CAPITAL, ACQUISITION OF ANOTHER COMPANY OR SALE OF THE COMPANY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below